Vir Biotechnology, Inc. Accrued Income Taxes, Current
Vir Biotechnology, Inc. (VIR) had Accrued Income Taxes, Current of $17.00 thousand as of 2024-06-30, per its 10-Q filed 2024-08-01.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedIncomeTaxesCurrent · last filed 2024-08-01
- 2024-06-30: Accrued Income Taxes, Current $17.00K.
- 2024-03-31: Accrued Income Taxes, Current $146.00K.
- 2023-12-31: Accrued Income Taxes, Current $149.00K.
- 2023-09-30: Accrued Income Taxes, Current $15.41M.
| Period end | Accrued Income Taxes, Current |
|---|---|
| 2024-06-30 | $17.00K 10-Q · filed 2024-08-01 |
| 2024-03-31 | $146.00K 10-Q · filed 2024-05-03 |
| 2023-12-31 | $149.00K 10-Q · filed 2024-08-01 |
| 2023-09-30 | $15.41M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $15.50M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $15.25M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $15.23M 10-K · filed 2024-02-26 |
| 2022-09-30 | $98.19M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $157.54M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $404.43M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $6.22M 10-K · filed 2023-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |